Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aquarius Surgical TechnologiesAQQRF Return-on-Tangible-Asset is 6.62% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Aquarius Surgical Technologies ranks worse than 76.37% on this metric.
The historical rank and industry rank for Aquarius Surgical Technologies's Return-on-Tangible-Asset or its related term are showing as below:
AQQRF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -327.84 Med: -94.23 Max: -30.58
Current: -30.58
During the past 13 years, Aquarius Surgical Technologies's highest Return-on-Tangible-Asset was -30.58%. The lowest was -327.84%. And the median was -94.23%.
AQQRF's Return-on-Tangible-Asset is ranked worse than 76.37% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.74
vs AQQRF: -30.58
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Aquarius Surgical Technologies Return-on-Tangible-Asset Related Terms
Aquarius Surgical Technologies Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AQQRF vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Aquarius Surgical Technologies's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aquarius Surgical Technologies Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aquarius Surgical Technologies's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Aquarius Surgical Technologies's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 6.62% mean?
Aquarius Surgical Technologies (AQQRF) has a Return-on-Tangible-Asset of 6.62% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Aquarius Surgical Technologies and its competitors. According to the industry distribution chart, Aquarius Surgical Technologies ranks #653 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 76.4%.
Is Aquarius Surgical Technologies' Return-on-Tangible-Asset too high?
Aquarius Surgical Technologies' current Return-on-Tangible-Asset is 6.62%. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.74. Aquarius Surgical Technologies' value of 6.62% is 794.6% above this industry median. Based on the distribution chart, Aquarius Surgical Technologies ranks #653 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Aquarius Surgical Technologies' Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aquarius Surgical Technologies ranks #653 out of 855 companies for Return-on-Tangible-Asset. This places Aquarius Surgical Technologies in the lower half of its industry. The industry median Return-on-Tangible-Asset is 0.74. Aquarius Surgical Technologies' value of 6.62% is 794.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.74, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aquarius Surgical Technologies's current Return-on-Tangible-Asset of 6.62% is 794.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Aquarius Surgical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aquarius Surgical Technologies's current Return-on-Tangible-Asset is 6.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aquarius Surgical Technologies stock overvalued right now?
Aquarius Surgical Technologies (AQQRF) has a current Return-on-Tangible-Asset of 6.62%. The current Return-on-Tangible-Asset is 6.62% and 794.6% above the Medical Devices & Instruments industry median of 0.74. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Aquarius Surgical Technologies (AQQRF), the current Return-on-Tangible-Asset is 6.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments. Through its subsidiary, the company operates as an international distributor, service, and support organization providing integrated laser-based solutions across multiple medical disciplines. These disciplines include urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery, many of which are now considered the standard of care for treatment. Geographically, the company generates maximum revenue from the sale of medical devices in the United States, and also has its presence in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQQRF has been successfully added to your 
